| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/24/2008 | US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates |
| 07/24/2008 | US20080176791 a mixture of antihemophilic factor, bulking agent selected from mannitol, glycine and alanine, stabilizer agents selected from sucrose, trehalose, raffinose and arginine, calcium chloride, sodium chloride and buffers, having storage stability |
| 07/24/2008 | US20080176785 Controlled release compositions |
| 07/24/2008 | US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases |
| 07/24/2008 | US20080176288 Colony stimulating factor fusion protein comprising polyanionic polymer for use tool to enhance drug delivery |
| 07/24/2008 | US20080175910 Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| 07/24/2008 | US20080175892 fullerene carbon nanotube linking to paclitaxel through polyethylene glycol, serinol, succinimidyl-3-(2-pyridyldithio)-propionate or succinic acid; anticarcinogenic agents treating lung cancer; drug target with antibody; aerosols drug delivery |
| 07/24/2008 | US20080175876 Novel Chitinase and Uses Thereof |
| 07/24/2008 | US20080175853 Virus-like particles for the induction of autoantibodies |
| 07/24/2008 | US20080175846 Antibodies against cancer antigen tmeff2 and uses thereof |
| 07/24/2008 | US20080175817 Biocompatible material composition adaptable to diverse therapeutic indications |
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | US20080175792 Emulsion; nanoparticles of liquid perfluorocarbon cores coated with lipid/surfactant coupled to integrin specific ligand; 3-({7-[(imidazol-2-ylamino)methyl]-1-methyl-4-oxo(3-hydroquinolyl)}carbonylamino)propanoic Acid adduct with Distearoyl-Glycero-3-Phosphoethanolamine-(PEG)-Maleimide deriv; nonantibody |
| 07/24/2008 | DE102006023365B4 Multiblockcopolymere mit Formgedächtniseigenschaften Multiblock copolymers having shape memory properties |
| 07/24/2008 | CA2676313A1 Novel cascade polymer complexes, processes for their preparation and pharmaceutical compositions comprising them |
| 07/24/2008 | CA2676010A1 Methods and compositions for the delivery of a therapeutic agent |
| 07/24/2008 | CA2675968A1 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 07/24/2008 | CA2675847A1 Pegylated a.beta. fab |
| 07/24/2008 | CA2675190A1 Cyclodextrin formulations |
| 07/24/2008 | CA2675157A1 Fibrin gel for controlled release of tgf-beta and uses thereof |
| 07/24/2008 | CA2675014A1 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites |
| 07/24/2008 | CA2673485A1 Gastric retention-type sustained-release levodopa preparation |
| 07/24/2008 | CA2667678A1 Toxin peptide therapeutic agents |
| 07/24/2008 | CA2648388A1 Treating cancer using electromagnetic fields in combination with other treatment regimens |
| 07/23/2008 | EP1946780A1 Controlled release solid preparation |
| 07/23/2008 | EP1946776A1 Stabilized TNFR-Fc composition comprising arginine |
| 07/23/2008 | EP1946763A1 Promoter for recovery from anesthesia |
| 07/23/2008 | EP1946761A1 Carrier composition for nucleic acid transport |
| 07/23/2008 | EP1946755A1 Jelly composition |
| 07/23/2008 | EP1946753A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1946748A1 Composition for administration to mammals or humans |
| 07/23/2008 | EP1946747A1 Pharmaceutical composition of improved stability containing taxane derivatives |
| 07/23/2008 | EP1946746A1 Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases |
| 07/23/2008 | EP1945655A2 Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof in particular for therapeutic purposes |
| 07/23/2008 | EP1945228A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 07/23/2008 | EP1945217A2 Combinations comprising a vegf receptor inhibitor and a penetration enhancer |
| 07/23/2008 | EP1945197A1 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 07/23/2008 | EP1945192A2 Nanoscale particles used as contrasting agents in magnetic resonance imaging |
| 07/23/2008 | EP1945191A2 Metal coordinated compositions |
| 07/23/2008 | EP1945183A2 Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound |
| 07/23/2008 | EP1945159A2 Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
| 07/23/2008 | EP1729724A4 Inhalent formulation containing sulfoalkyl ether gamma-cyclodextryn and corticosteroid |
| 07/23/2008 | EP1571929B1 A process for the preparation of antioxidant conserve from indian curry leaves (murraya koenigii spreng.) |
| 07/23/2008 | EP1562572B1 Pharmaceutical Solid Dispersions of Modafinil Compounds |
| 07/23/2008 | EP1499289B1 Volume efficient controlled release dosage form |
| 07/23/2008 | EP1485145B1 Multiple compartment bag assembly containing dialysis fluid |
| 07/23/2008 | EP1471995B1 Encapsulation process and encapsulated compositions |
| 07/23/2008 | EP1435915B1 Oral dosage forms for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 07/23/2008 | EP1345743B1 Electroprocessed collagen |
| 07/23/2008 | EP1326607B1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids |
| 07/23/2008 | EP1296673B1 Antimicrobial coatings |
| 07/23/2008 | EP1272167B1 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation |
| 07/23/2008 | EP1239829B1 Devices for the delivery of drugs having antiprogestinic properties |
| 07/23/2008 | EP1181036B1 Pharmaceutical compositions of erythropoietin |
| 07/23/2008 | EP1126830B1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 07/23/2008 | CN101228212A Novel carbosilane dendrimers, preparation method thereof and use of same |
| 07/23/2008 | CN101228183A Method of purifying APO-2 ligand/TRAIL using crystallisation in the cold |
| 07/23/2008 | CN101227952A Emulsified skin external preparation and method for stabilizing the skin external preparation |
| 07/23/2008 | CN101227951A Emulsified skin external preparation and method for stabilizing the skin external preparation |
| 07/23/2008 | CN101227896A Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 07/23/2008 | CN101227894A Rapidly disintegratable oral tablet |
| 07/23/2008 | CN101227892A Buccal delivery system |
| 07/23/2008 | CN101227891A Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 07/23/2008 | CN101227886A Gelatin-containing topical composition |
| 07/23/2008 | CN101225424A Single-glucopyranoside of cyclomembranousol, preparation method, medicament combination and uses thereof |
| 07/23/2008 | CN101225146A Chitosan-ketoprofen grafts and preparation method thereof |
| 07/23/2008 | CN101225133A Thermo-sensitive physical gel using chemical cross-linking gel particle as construction unit and preparation method thereof |
| 07/23/2008 | CN101224306A Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof |
| 07/23/2008 | CN101224305A Folic acid modification of chitosan nucleophilic NO donator and compounding method thereof |
| 07/23/2008 | CN101224304A Function of fructooligosaccharide in preparing plaster for internal use |
| 07/23/2008 | CN101224303A Skin penetration agent |
| 07/23/2008 | CN101224298A Propofol compounds |
| 07/23/2008 | CN101224297A Application of recombinant human endostain in preparing medicine |
| 07/23/2008 | CN101224296A Stable recombinant human endostain preparation and preparing method thereof |
| 07/23/2008 | CN101224277A Sticking membrane for mucous membrane after septoplasty |
| 07/23/2008 | CN101224273A Preparing method of Jiaozhi soft capsule |
| 07/23/2008 | CN101224265A Plaster for treating fracture dialocation |
| 07/23/2008 | CN101224244A Children clearing heat suppository and preparing method thereof |
| 07/23/2008 | CN101224238A External methyl tes tosterone preparation |
| 07/23/2008 | CN101224236A Chinese traditional medicine compounds for treating vifiligo and preparing method thereof |
| 07/23/2008 | CN101224228A Panax notoginseng saponins freeze-dried powder injection and preparing method thereof |
| 07/23/2008 | CN101224227A External preparation of essential oil from Bupleurum root |
| 07/23/2008 | CN101224222A Cydiodine buccal tablet and preparing method thereof |
| 07/23/2008 | CN101224217A Skeleton type roxithromycin sustained release pellet capsule |
| 07/23/2008 | CN101224211A Entecavir solid dispersoid, medicine compounds and preparing method and applications thereof |
| 07/23/2008 | CN101224210A Mizolastine sustained release capsule |
| 07/23/2008 | CN101224206A Loperamide hydrochloride percutaneous absorption preparation |
| 07/23/2008 | CN101224205A Compound of atorvastatin and levorotatory amlodipine and preparing method thereof |
| 07/23/2008 | CN101224204A Butoconazole nitrate soft capsule for vagina and preparing method thereof |
| 07/23/2008 | CN101224203A Tanshinone IIA microemulsions and preparing method thereof |
| 07/23/2008 | CN101224198A Preparing method of breviscapinun dropping pills |
| 07/23/2008 | CN101224196A Ambroxol hydrochloride freeze-dried powder injection and preparing method thereof |
| 07/23/2008 | CN101224195A Compounding method of cefpirome sulfate raw material and uses thereof |
| 07/23/2008 | CN101224194A Silybin guest nanometer particle and preparing method thereof |
| 07/23/2008 | CN101224193A Compound sustained release injection containing newborn blood vessel inhibitor and cytotoxic drugs |
| 07/23/2008 | CN101224192A Injection containing newborn blood vessel inhibitor |
| 07/23/2008 | CN101224191A Compound sustained release injection containing newborn blood vessel inhibitor |
| 07/23/2008 | CN101224190A Compound sustained release injection containing newborn blood vessel inhibitor fumagillin |
| 07/23/2008 | CN101224189A Sustained release injection containing newborn blood vessel inhibitor |